Leiomyoma clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Prescription of Letrozole for Uterine Myoma
open to eligible females ages 21-53
The PLUM Study is a randomized, double-blinded, 2-arm, parallel-group, placebo-controlled trial is designed to compare the efficacy of letrozole versus placebo on leiomyoma-related symptoms and quality of life as well as leiomyoma and uterine size.
at UCSF
Our lead scientists for Leiomyoma research studies include Vanessa Jacoby.
Last updated: